The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients.
The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients. Here's how it works and what a doctor thinks.The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication.
and up to $1,200 a year for the Wegovy injection with a 12-month subscription, pharmaceutical giant Novo Nordisk announced on Tuesday, March 31.The program is now available for self-pay patients who don’t have traditional insurance, says Jamey Millar, the company’s executive vice president of U.S. operations. “We want patients to stay with therapy over time, and that’s what this subscription model encourages,” Millar told NBC News’ Anne Thompson. Dr. Jorge Moreno, a Yale medicine obesity specialist, says 20-25% of his patients pay for GLP-1 drugs out of pocket since insurance coverage can be unpredictable. "This subscription plan could help them if they are able to afford $250 a month, which is still a lot," he told Thompson. approved for weight loss. Both drugs contain semaglutide, which mimics a hormone the body produces after eating. This leads to decreased appetite and feelings of fulness, helping people lose weight.It’s available through Ro, WeightWatchers and LifeMD, starting March 31.Self-pay patients can choose a three-, six- or 12-month Wegovy subscription. People who are already pay for those telehealth services will benefit greatly because their their costs will go down, Moreno said. But others will have to pay a membership fee to join and take part in the subscription program, which may limit any savings they'll experience, he adds. Moreno also wondered about what kind of"off ramp" would be offered to patients who want to stop taking the medication during the subscription period. "Patients that sign up to any of these three companies, they should really be aware of: What are their options to signing up? What happens if the medication doesn't work for them?" Moreno said. "What happens if the medication causes them significant side effects? How will that company address it? And what if they want to stop? What if they don't want to be part of this company anymore?"Patients will pay the same price for the injection regardless of the Wegovy dose they need.A six-month subscription costs $299 per month, a savings of $600 per year.The program covers 9 milligram and 25 milligram doses. The lower doses currently cost less as part of a limited time offer.A six-month subscription costs $269 per month, a savings of $360 per yearEXCLUSIVE: Woman Who Beat Colon Cancer 4 Times By Age 41 Recalls Her Subtle, Early Symptoms EXCLUSIVE: William Daniels, Mr. Feeny of 'Boy Meets World,' Turns 99! His 4 Simple Tips for a Happy Life
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
BTS Earns 7th No. 1 Album on Billboard 200 With ‘ARIRANG’BTS' 'ARIRANG' debuts at No. 1 on the Billboard 200 albums chart, while Luke Combs' 'The Way I Am' bows at No. 2.
Read more »
Hyperliquid traders in Tokyo get 200-millisecond edge, Glassnode research showsHyperliquid’s validators cluster in AWS Tokyo alongside Binance, BitMEX and KuCoin, giving nearby traders a latency advantage, Glassnode data shows
Read more »
RM Expresses ‘Luv and Gratitude’ as BTS Tops the Billboard 200 & Hot 100 ChartsIn a new Instagram story, RM expressed 'luv and gratitude' As BTS tops the Billboard 200 and Hot 100 Charts with 'ARIRANG' and 'SWIM,' respectively.
Read more »
BTS’s “SWIM” Tops Billboard Charts Including Hot 100 + “ARIRANG” Dominates Global 200BTS has sweeped several Billboard charts with their long-awaited comeback! In addition to 'ARIRANG' topping the Billboard 200, the title track 'SWIM'
Read more »
Former Fernandina Beach Winn-Dixie reopens Thursday as Aldi; gift card giveaways for first 200 customersA former Winn-Dixie in Fernandina Beach will open Thursday after being converted into an Aldi, according to our news partners at the Jacksonville Daily Record.
Read more »
New Wegovy Subscription Program Offers Lower Cost For GLP-1 Drugs: EXCLUSIVEA. Pawlowski is a TODAY health reporter focusing on health news and features. Previously, she was a writer, producer and editor at CNN.
Read more »